Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.

Source:http://linkedlifedata.com/resource/pubmed/id/18468446

Bioorg. Med. Chem. 2008 Jun 1 16 11 6086-102

Download in:

View as

General Info

PMID
18468446